In a new step toward employing artificial intelligence in medicine, the Nolla Derm system by Nolla Health has received authorization in the US state of Utah to prescribe adult acne treatments based on photographs and questionnaires, as part of a controlled medical trial.
The process begins with the user filling out a health questionnaire and taking photos of their face via the application. The algorithm then analyzes the data and selects a treatment from a predefined list of physician-approved medications and topical treatments. Cases that do not meet the system's criteria are referred to a specialist physician.
Gradual independence and medical oversight
The trial is being implemented in phases, as a physician reviews the prescriptions of the first 100 patients before the system is allowed to prescribe treatment for the next 500 patients, with daily reviews of medical reports. In a later stage, oversight transitions to weekly selective reviews.
The company states that the system's recommendations match the opinions of specialist physicians by 96%, but this percentage is based on the company's own data and, according to available information, has not undergone independent verification.
The app's use is restricted to adults over 18 residing in the state of Utah, with monthly treatment reviews and the possibility of consulting a doctor when needed.
Although the trial represents a notable step in using artificial intelligence in healthcare, independent verification of its accuracy and safety remains essential to evaluate its effectiveness and the possibility of expanding its use in the future.
